Diabetes Nerve Damage and Muscle Mass in Type 2 Diabetes
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study examines how nerve damage from diabetes (diabetic neuropathy) relates to muscle loss in people with type 2 diabetes. It aims to help understand and possibly prevent muscle weakness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 45 years or older
- You must have type 2 diabetes
- You cannot have a serious heart or lung condition, or a neurological disorder like Parkinson's disease or a past stroke that makes daily activities hard
- You cannot have other causes of nerve damage, such as heavy alcohol use, poor nutrition, or drug addiction
- You cannot be on long-term steroids
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common muscle loss (sarcopenia) is in older people with long-standing type 2 diabetes. It aims to find out if there is a link so that doctors can spot muscle problems earlier and help patients stay stronger.
This study tests whether a special exercise program can help middle-aged and older adults who have both type 2 diabetes and muscle loss. It aims to improve muscle strength, balance, and overall health.
This study looks at whether adults with type 2 diabetes have weaker breathing muscles (a condition called respiratory muscle sarcopenia). They will measure your breathing and other muscles to see how diabetes affects them.
This study looks at muscle loss (sarcopenia) in people with multiple sclerosis. It aims to understand what factors are linked to muscle loss, which could help improve care.
This trial tests whether a specific strength-training program (called progressive resistance training) can help older adults with both type 2 diabetes and sarcopenia (muscle loss) improve muscle strength and overall function.
This study looks at how common muscle loss and weakness are in people with multiple sclerosis (MS) at different stages of the disease. It also checks how muscle loss relates to everyday function. The goal is to better understand these issues to improve care.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.